DBV Technologies (DBVT) Other Operating Expenses (2020 - 2026)
DBV Technologies (DBVT) posted Other Operating Expenses of $5.5 million for Q2 2026, up 12.24% sequentially from $4.9 million in Q1 2026, and up 1275.0% YoY from $400000.0 in Q2 2025.
DBV Technologies (DBVT) Other Operating Expenses (2020 - 2026) Analysis & Trends
DBV Technologies has reported Other Operating Expenses for 7 years, with the latest figure at $5.5 million in Q2 2026.
- Quarterly Other Operating Expenses rose 1275.0% year-over-year to $5.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.9 million (up 701.24% YoY) and the FY2025 annual result came in at $3.2 million, up 21.17% from the prior year.
- Other Operating Expenses grew to $5.5 million in Q2 2026 per DBVT's latest filing, from $4.9 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $5.5 million in Q2 2026 and troughed at -$51000.0 in Q4 2022.
- A 5-year average of $1.1 million and a median of $591000.0 in 2023 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses tumbled 103.67% in 2022, then soared 1717.65% in 2023.
- Over 5 years, Other Operating Expenses stood at -$51000.0 in 2022, then jumped by 1717.65% to $825000.0 in 2023, then tumbled by 52.0% to $396000.0 in 2024, then soared by 244.19% to $1.4 million in 2025, then soared by 303.52% to $5.5 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $5.5 million, $4.9 million, and $1.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.50 Mn |
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 396,000.00 |
| Sep 30, 2024 | 519,000.00 |
| Jun 30, 2024 | 986,000.00 |
| Mar 31, 2024 | 757,000.00 |
| Dec 31, 2023 | 825,000.00 |
| Sep 30, 2023 | 663,000.00 |
| Jun 30, 2023 | 517,000.00 |
| Mar 31, 2023 | 433,000.00 |
| Dec 31, 2022 | -51,000.00 |
| Sep 30, 2022 | 159,000.00 |
| Jun 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 464,000.00 |
| Dec 31, 2021 | 1.39 Mn |
| Sep 30, 2021 | 1.07 Mn |